Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Rare disease clinical trials: challenges and best practices — Giuseppe Remuzzi (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Rare disease clinical trials: challenges and best practices
Shared by
Giuseppe Remuzzi
Rare disease clinical trials: challenges and best practices
Article
2024
en
Authors
Giuseppe Remuzzi
Related publications
Article
2008
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone
Adrían V. Hernández
,
Esteban Walker
,
John P A Ioannidis
,
Michael W. Kattan
Article
2014
Best practices for biofuels
Heather Youngs
,
Chris Somerville
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Editorial Material
2020
Tutorials and Articles on Best Practices
Raymond E. Schaak
,
Reginald M. Penner
,
Jillian M. Buriak
,
Frank Caruso
,
Manish Chhowalla
,
Yury Gogotsi
,
Paul Mulvaney
,
Wolfgang J. Parak
,
Paul S. Weiss
Article
2021
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities
Rafael Dal‐Ré
,
Linda‐Gail Bekker
,
Christian Gluud
,
Søren Holm
,
Vivekanand Jha
,
Gregory A. Poland
,
Frits R. Rosendaal
,
Brigitte Schwarzer‐Daum
,
Esperança Sevene
,
Halidou Tinto
,
Teck Chuan Voo
,
Nadarajah Sreeharan
The Lancet Infectious Diseases
Article
2021
Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
Perrine Janiaud
,
Lars G. Hemkens
,
John P A Ioannidis
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.